Listerine With Fluoride Proposed Six-Month Study To Be Reviewed By FDA
This article was originally published in The Tan Sheet
Executive Summary
Pfizer Consumer Healthcare plans to conduct a six-month clinical study involving at least 300 subjects to determine whether adding .02% sodium fluoride to the company's Listerine mouthrinse affects the antiplaque/ antigingivitis effectiveness of the product
You may also be interested in...
FreshBurst Listerine Study Must Exhibit 20% Gingivitis Reduction – FDA
A six-month study of FreshBurst Listerine with Fluoride will need to show "a 20% reduction in gingivitis" over the control to receive agency approval, FDA told Pfizer execs at an Aug. 27 meeting
FreshBurst Listerine Study Must Exhibit 20% Gingivitis Reduction – FDA
A six-month study of FreshBurst Listerine with Fluoride will need to show "a 20% reduction in gingivitis" over the control to receive agency approval, FDA told Pfizer execs at an Aug. 27 meeting
FreshBurst Listerine Study Must Exhibit 20% Gingivitis Reduction – FDA
A six-month study of FreshBurst Listerine with Fluoride will need to show "a 20% reduction in gingivitis" over the control to receive agency approval, FDA told Pfizer execs at an Aug. 27 meeting